{
  "variants": [
    {
      "variant": "LRRK2 G2019S",
      "gene": "LRRK2",
      "protein_change": {
        "reference": "G",
        "alternate": "S",
        "position": "2019"
      },
      "variant_string_id": "LRRK2 G2019S",
      "functional_evidence_aim": "Pathogenic",
      "acmg_flowchart": {
        "step_1": {
          "question": "Define the disease mechanism",
          "answer": "Yes",
          "rationale": "The study links LRRK2 variants to dopaminergic neuron degeneration and mitochondrial dysfunction, consistent with Parkinson's disease mechanisms."
        },
        "step_2": {
          "question": "Evaluate applicability of the assay",
          "answer": "Yes",
          "rationale": "Transgenic Drosophila models are well-established for studying Parkinson's-related neurodegeneration and mitochondrial defects."
        },
        "step_3": {
          "sub_step_3a": {
            "question": "Basic controls (normal/abnormal)",
            "answer": "Yes",
            "rationale": "Wild-type LRRK2 was used as a negative control, and the variants (G2019S, Y1699C, G2385R) showed phenotypic differences."
          },
          "sub_step_3b": {
            "question": "Accepted/validated assay",
            "answer": "No",
            "rationale": "The paper does not explicitly cite prior validation of the Drosophila model for these specific variants."
          },
          "sub_step_3c": {
            "question": "Variant controls (pathogenic/benign)",
            "answer": "No",
            "rationale": "No known pathogenic or benign variants were used as controls in the study."
          }
        },
        "step_4": {
          "sub_step_4a": {
            "question": "Statistical analyses (OddsPath)",
            "answer": "No",
            "rationale": "The abstract does not report p-values, effect sizes, or OddsPath calculations."
          },
          "sub_step_4b": {
            "question": "Number of benign/pathogenic controls",
            "answer": "1 (wild-type)",
            "rationale": "Only wild-type LRRK2 was used as a control, with no additional variant controls."
          }
        },
        "evidence_strength": "Max PS3_supporting"
      }
    },
    {
      "variant": "LRRK2 Y1699C",
      "gene": "LRRK2",
      "protein_change": {
        "reference": "Y",
        "alternate": "C",
        "position": "1699"
      },
      "variant_string_id": "LRRK2 Y1699C",
      "functional_evidence_aim": "Pathogenic",
      "acmg_flowchart": {
        "step_1": {
          "question": "Define the disease mechanism",
          "answer": "Yes",
          "rationale": "The study links LRRK2 variants to dopaminergic neuron degeneration and mitochondrial dysfunction, consistent with Parkinson's disease mechanisms."
        },
        "step_2": {
          "question": "Evaluate applicability of the assay",
          "answer": "Yes",
          "rationale": "Transgenic Drosophila models are well-established for studying Parkinson's-related neurodegeneration and mitochondrial defects."
        },
        "step_3": {
          "sub_step_3a": {
            "question": "Basic controls (normal/abnormal)",
            "answer": "Yes",
            "rationale": "Wild-type LRRK2 was used as a negative control, and the variants (G2019S, Y1699C, G2385R) showed phenotypic differences."
          },
          "sub_step_3b": {
            "question": "Accepted/validated assay",
            "answer": "No",
            "rationale": "The paper does not explicitly cite prior validation of the Drosophila model for these specific variants."
          },
          "sub_step_3c": {
            "question": "Variant controls (pathogenic/benign)",
            "answer": "No",
            "rationale": "No known pathogenic or benign variants were used as controls in the study."
          }
        },
        "step_4": {
          "sub_step_4a": {
            "question": "Statistical analyses (OddsPath)",
            "answer": "No",
            "rationale": "The abstract does not report p-values, effect sizes, or OddsPath calculations."
          },
          "sub_step_4b": {
            "question": "Number of benign/pathogenic controls",
            "answer": "1 (wild-type)",
            "rationale": "Only wild-type LRRK2 was used as a control, with no additional variant controls."
          }
        },
        "evidence_strength": "Max PS3_supporting"
      }
    },
    {
      "variant": "LRRK2 G2385R",
      "gene": "LRRK2",
      "protein_change": {
        "reference": "G",
        "alternate": "R",
        "position": "2385"
      },
      "variant_string_id": "LRRK2 G2385R",
      "functional_evidence_aim": "Pathogenic",
      "acmg_flowchart": {
        "step_1": {
          "question": "Define the disease mechanism",
          "answer": "Yes",
          "rationale": "The study links LRRK2 variants to dopaminergic neuron degeneration and mitochondrial dysfunction, consistent with Parkinson's disease mechanisms."
        },
        "step_2": {
          "question": "Evaluate applicability of the assay",
          "answer": "Yes",
          "rationale": "Transgenic Drosophila models are well-established for studying Parkinson's-related neurodegeneration and mitochondrial defects."
        },
        "step_3": {
          "sub_step_3a": {
            "question": "Basic controls (normal/abnormal)",
            "answer": "Yes",
            "rationale": "Wild-type LRRK2 was used as a negative control, and the variants (G2019S, Y1699C, G2385R) showed phenotypic differences."
          },
          "sub_step_3b": {
            "question": "Accepted/validated assay",
            "answer": "No",
            "rationale": "The paper does not explicitly cite prior validation of the Drosophila model for these specific variants."
          },
          "sub_step_3c": {
            "question": "Variant controls (pathogenic/benign)",
            "answer": "No",
            "rationale": "No known pathogenic or benign variants were used as controls in the study."
          }
        },
        "step_4": {
          "sub_step_4a": {
            "question": "Statistical analyses (OddsPath)",
            "answer": "No",
            "rationale": "The abstract does not report p-values, effect sizes, or OddsPath calculations."
          },
          "sub_step_4b": {
            "question": "Number of benign/pathogenic controls",
            "answer": "1 (wild-type)",
            "rationale": "Only wild-type LRRK2 was used as a control, with no additional variant controls."
          }
        },
        "evidence_strength": "Max PS3_supporting"
      }
    }
  ]
}